Skip to content

A Randomized Controlled Study on the Intervention of Functional Constipation with Atractylodes Macrocephala Essential Oil Umbilical Patches

A Randomized Controlled Trial on the Efficacy of Atractylodes Macrocephala Essential Oil Umbilical Patches versus Placebo in the Treatment of Functional Constipation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115754
Enrollment
Unknown
Registered
2025-12-30
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional constipation

Interventions

Intervention group (Atractylodes Essential Oil):(1) Skin Cleansing: Before applying the patch, the patient lies in a supine position with the umbilicus exposed. The skin is disinfected with a 75% alco
Control group (placebo):Apply a umbilical patch containing 1ml of Johnson's Baby Nourishing Skin Oil placebo to the Shenque acupoint, and all other steps are the same as those in the intervention grou

Sponsors

Shenzhen Hospital of Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 40 years; 2. Meet the diagnostic criteria for Rome IV functional constipation; 3. Patients with mild functional constipation; 4. Willing to participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Participants who participated in other clinical trials within 4 weeks before the start of this study or participated in other clinical trials during the conduct of this study; 2. Patients who underwent general anesthesia within one week or are scheduled to undergo general anesthesia next week; 3. Patients who have been taking antidepressants, antispasmodics, iron supplements, and other medications that are prone to causing constipation for a long time; 4. Patients with severe diseases of the digestive system, cardiovascular system, urinary system, neuroendocrine system, or malignant tumors; 5. Patients with skin irritation, injury, or peeling at the umbilicus; women in the preconception period, pregnant women, and lactating women; 6. Patients with cognitive dysfunction or mental abnormalities; 7. Patients who are currently being treated for constipation with other drug methods; 8. Patients known to be allergic to Atractylodes macrocephala, tape, or alcohol.

Design outcomes

Primary

MeasureTime frame
Wexner Constipation Score;

Secondary

MeasureTime frame
Bristol Stool Form Scale;

Countries

China

Contacts

Public ContactMa Menghui

Shenzhen Hospital of Shanghai University of Traditional Chinese Medicine

58817745@qq.com+86 135 9036 1476

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026